Company Background :
Aurobindo Pharma Limited (Aurobindo) is an India-based pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical. Aurobindo also manufactures and commercializes active pharmaceutical ingredients (APIs) and generic finished dosages for various markets.
The Company's product portfolio is spread over six therapeutic/product areas, including antibiotics, anti-retrovirals, chorionic villus sampling (CVS), central nervous system (CNS), gastroenterologicals and anti-allergics. It has presence in various therapeutic segments, such as semi-synthetic penicillin's, antibiotics, neurosciences, cardio vasculars, anti-retrovirals, diabetics and gastroenterology, among others.
The Company operates across various divisions, including API manufacturing, formulation manufacturing, chemical research and development, formulation research and development, and overseas operations.
Stock Performance :
During the last 1 year the scrip has lost substantially peaked at Rs.891 sunk to a low of Rs.594 roughly losing 30%.
During the last 6 months is also negative from a low of Rs.588 had fallen from high of Rs.888.
Three months movement is also negative touched a low of Rs.708 had fallen from high of Rs.820.
Our Recommendation :
Buy Range - 750
Sell Range 850 + Short Term 3 months
1200 + Long Term more than 12 months
Our advise to investors is to buy on declines and hold
Raghav
Smart Investor -
Equity Research
No.24 Pattamal Plaza
3rd Cross Kammanahalli
BANGALORE 560084
Whatsapp -09880080321
Smart Investor
BSE, NSE SharesTips
Aurobindo Pharma Limited (Aurobindo) is an India-based pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical. Aurobindo also manufactures and commercializes active pharmaceutical ingredients (APIs) and generic finished dosages for various markets.
The Company's product portfolio is spread over six therapeutic/product areas, including antibiotics, anti-retrovirals, chorionic villus sampling (CVS), central nervous system (CNS), gastroenterologicals and anti-allergics. It has presence in various therapeutic segments, such as semi-synthetic penicillin's, antibiotics, neurosciences, cardio vasculars, anti-retrovirals, diabetics and gastroenterology, among others.
The Company operates across various divisions, including API manufacturing, formulation manufacturing, chemical research and development, formulation research and development, and overseas operations.
Stock Performance :
During the last 1 year the scrip has lost substantially peaked at Rs.891 sunk to a low of Rs.594 roughly losing 30%.
During the last 6 months is also negative from a low of Rs.588 had fallen from high of Rs.888.
Three months movement is also negative touched a low of Rs.708 had fallen from high of Rs.820.
Our Recommendation :
Buy Range - 750
Sell Range 850 + Short Term 3 months
1200 + Long Term more than 12 months
Our advise to investors is to buy on declines and hold
Raghav
Smart Investor -
Equity Research
No.24 Pattamal Plaza
3rd Cross Kammanahalli
BANGALORE 560084
Whatsapp -09880080321
Smart Investor
BSE, NSE SharesTips
No comments:
Post a Comment